Regulation of and challenges in targeting NAD+ metabolism

ME Migaud, M Ziegler, JA Baur - Nature Reviews Molecular Cell …, 2024 - nature.com
Nicotinamide adenine dinucleotide, in its oxidized (NAD+) and reduced (NADH) forms, is a
reduction–oxidation (redox) co-factor and substrate for signalling enzymes that have …

[HTML][HTML] Neuroprotection in glaucoma: Mechanisms beyond intraocular pressure lowering

JR Tribble, F Hui, H Quintero, S El Hajji, K Bell… - Molecular aspects of …, 2023 - Elsevier
Glaucoma is a common, complex, multifactorial neurodegenerative disease characterized
by progressive dysfunction and then loss of retinal ganglion cells, the output neurons of the …

Selective inhibitors of SARM1 targeting an allosteric cysteine in the autoregulatory ARM domain

HC Feldman, E Merlini, C Guijas, KE DeMeester… - Proceedings of the …, 2022 - pnas.org
The nicotinamide adenine dinucleotide hydrolase (NADase) sterile alpha toll/interleukin
receptor motif containing-1 (SARM1) acts as a central executioner of programmed axon …

SARM1 is a multi-functional NAD (P) ase with prominent base exchange activity, all regulated bymultiple physiologically relevant NAD metabolites

C Angeletti, A Amici, J Gilley, A Loreto, AG Trapanotto… - Iscience, 2022 - cell.com
Summary SARM1 is an NAD (P) glycohydrolase and TLR adapter with an essential,
prodegenerative role in programmed axon death (Wallerian degeneration). Like other NAD …

Enrichment of SARM1 alleles encoding variants with constitutively hyperactive NADase in patients with ALS and other motor nerve disorders

J Gilley, O Jackson, M Pipis, MA Estiar, A Al-Chalabi… - Elife, 2021 - elifesciences.org
SARM1, a protein with critical NADase activity, is a central executioner in a conserved
programme of axon degeneration. We report seven rare missense or in-frame microdeletion …

Augustus Waller's foresight realized: SARM1 in peripheral neuropathies

S Geisler - Current Opinion in Neurobiology, 2024 - Elsevier
Peripheral neuropathy is a common neurodegenerative condition characterized by
numbness, tingling, pain, and weakness that frequently starts in the distal limbs. Arising from …

[HTML][HTML] NMN: the NAD precursor at the intersection between axon degeneration and anti-ageing therapies

A Loreto, C Antoniou, E Merlini, J Gilley… - Neuroscience …, 2023 - Elsevier
The past 20 years of research on axon degeneration has revealed fine details on how NAD
biology controls axonal survival. Extensive data demonstrate that the NAD precursor NMN …

Sarm1-dependent axon degeneration: Nucleotide signaling, neurodegenerative disorders, toxicity, and therapeutic opportunities

HY McGuinness, W Gu, Y Shi, B Kobe… - The …, 2024 - journals.sagepub.com
Axons are an essential component of the nervous system, and axon degeneration is an
early feature of many neurodegenerative disorders. The NAD+ metabolome plays an …

Context-specific stress causes compartmentalized SARM1 activation and local degeneration in cortical neurons

FI Hinz, CLM Villegas, JT Roberts, H Yao… - Journal of …, 2024 - jneurosci.org
Sterile alpha and TIR motif containing 1 (SARM1) is an inducible NADase that localizes to
mitochondria throughout neurons and senses metabolic changes that occur after injury …

Programmed axon death: a promising target for treating retinal and optic nerve disorders

A Loreto, E Merlini, MP Coleman - Eye, 2024 - nature.com
Programmed axon death is a druggable pathway of axon degeneration that has garnered
considerable interest from pharmaceutical companies as a promising therapeutic target for …